Genetic and Transcriptomic Biomarkers in Neurodegenerative Diseases: Current Situation and the Road Ahead
Neurodegenerative diseases are etiologically and clinically heterogeneous conditions, often reflecting a spectrum of disease rather than well-defined disorders. The underlying molecular complexity of these diseases has made the discovery and validation of useful biomarkers challenging. The search of...
Main Authors: | Julie Lake, Catherine S. Storm, Mary B. Makarious, Sara Bandres-Ciga |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-04-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/10/5/1030 |
Similar Items
-
Proteotoxicity and Neurodegenerative Diseases
by: Clara Ruz, et al.
Published: (2020-08-01) -
Salivary Biomarkers: Future Approaches for Early Diagnosis of Neurodegenerative Diseases
by: Giovanni Schepici, et al.
Published: (2020-04-01) -
Molecular Biomarkers and Their Implications for the Early Diagnosis of Selected Neurodegenerative Diseases
by: Julia Doroszkiewicz, et al.
Published: (2022-04-01) -
Paraoxonase Role in Human Neurodegenerative Diseases
by: Cadiele Oliana Reichert, et al.
Published: (2020-12-01) -
Pyrimidine analogues for the management of neurodegenerative diseases
by: Swati Pant, et al.
Published: (2022-12-01)